Skip to main content
. 2019 Nov 13;19(1):142–154. doi: 10.1074/mcp.RA119.001808

Fig. 5.

Fig. 5.

Association of NDUFB8 and ATP5B with better survival in NPC patients. A, The clinical pathological parameters of the NPC patients. B, Expression levels of NDUFB8 and ATPT5B proteins in NPC tumor cells. Cells were immunohistochemically stained with protein-specific antibodies, and the results are demonstrated at 400x magnification. C, Kaplan-Meier survival analysis of local recurrence-free survival curves for NPC patients with NDUFB8 expression (left panel) or ATP5B expression (right panel). D, Correlation between NDUFB8 expression and ATP5B expression in NPC tissues. E, Kaplan-Meier survival analysis of local recurrence-free survival curves for NPC patients with combine expression of NDUFB8 and ATP5B. Symbols: *p < 0.05; **p < 0.01.